0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Pulmonary Lymphangitic Metastases From Breast Carcinoma

Harry S. Goldsmith, MD; Henry D. Bailey, MD; Edward L. Callahan, MD; Edward J. Beattie Jr., MD
Arch Surg. 1967;94(4):483-488. doi:10.1001/archsurg.1967.01330100047007.
Text Size: A A A
Published online

PULMONARY lymphangitic carcinoma is generally regarded as a diffuse permeation of pulmonary and pleural lymphatics resulting in a characteristic, clinical, radiological, and pathological appearance (Fig 1). It is a disease process generally regarded as uniformly fatal soon after a diagnosis is made. The purpose of this study was to evaluate whether the above concepts were correct, based on a retrospective study of the natural history of the disease.

The main method in diagnosing lymphangitic carcinoma consists in obtaining a characteristic radiological picture. Since pathological proof of the diagnosis in the living is usually lacking, a decision was made to study carefully the lungs of a uniform group of patients who are known to have a relatively high incidence of lymphangitic carcinoma.

There were 365 consecutive autopsies performed from Jan 1, 1960, to Dec 31, 1964, on all patients who died from breast carcinoma at the Memorial Sloan-Kettering Cancer Center. All

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();